An up-to-date publications list with citations is also available on my Google Scholar Profile

I currently have 5 first author and 10 co-authored publications and 1 patent


First author publications

★ symbol indicates that both authors contributed equally to the work

Crisan A, Gardy JL, Munzner T (2016) On Regulatory and Organizational Constraints in Visualization Design and Evaluation. BELIV 16 Proceedings of the Sixth Workshop on Beyond Time and Errors on Novel Evaluation Methods for Visualization [doi] [pdf]

Crisan A, Wong HY, Johnston JC, Tang P, Colijn C, Otterstatter M, Hiscoe L, Parker R, Pollock SL, Gardy JL (2015) Spatio-temporal analysis of tuberculous infection risk among clients of a homeless shelter during an outbreak. The International Journal of Tuberculosis and Lung Disease [doi] [pdf]

Alshalalfa M★,Crisan A★, Vergara IA, Ghadessi M, Buerki C, Erho N, Yousefi K, Sierocinski T, Haddad Z, Black PC, Karnes RJ, Jenkins RB, Davicioni E (2014) Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence. BJU international [doi] [pdf]

Erho N★, Crisan A★, Vergara IA, Mitra AP, Ghadessi M, Buerki C, Bergstralh EJ, Kollmeyer T, Fink S, Haddad Z, Zimmermann B, Sierocinski T, Ballman KV, Triche TJ, Black PC, Karnes RJ, Klee G, Davicioni E, Jenkins RB (2013) Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. PLOS ONE [doi] [pdf]

Crisan A, Goya R, Ha G, Ding J, Prentice LM, Oloumi A, Senz J, Zeng T, Tse K, Delaney A, Marra MA, Huntsman DG, Hirst M, Aparicio S, Shah SP (2012) Mutation discovery in regions of segmental cancer genome amplifications with CoNAn-SNV: a mixture model for next generation sequencing of tumors. PLOS ONE [doi] [pdf]

Co-authored publications

Miller RR, Langille MG, Montoya V, Crisan A, Stefanovic A, Martin I, Hoang L, Patrick DM, Romney M, Tyrrell G, Jones SJ, Brinkman FS, Tang P (2016) Genomic Analysis of a Serotype 5 Streptococcus pneumoniae Outbreak in British Columbia, Canada, 2005 - 2009. Canadian Journal of Infectious Diseases and Medical Microbiology [doi]

Hatherell H, Didelot X, Pollock SL, Tang P, Crisan A, Johnston JC, Colijn C, Gardy JL (2016) Declaring a tuberculosis outbreak over with genomic epidemiology. Microbial Genomics [doi]

Cooperberg MR, Davicioni E, Crisan A, Jenkins RB, Ghadessi M, Karnes RJ (2015) Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort. European urology [doi]

Ross AE, Feng FY, Ghadessi M, Erho N, Crisan A , Buerki C, Sundi D, Mitra AP, Vergara IA, Thompson DJ, Triche TJ, Davicioni E, Bergstralh EJ, Jenkins RB, Karnes RJ, Schaeffer EM (2014) A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. Prostate cancer and prostatic diseases [doi]

Karnes RJ, Bergstralh EJ, Davicioni E, Ghadessi M, Buerki C, Mitra AP, Crisan A, Erho N, Vergara IA, Lam LL, Carlson R, Thompson DJ, Haddad Z, Zimmermann B, Sierocinski T, Triche TJ, Kollmeyer T, Ballman KV, Black PC, Klee GG, Jenkins RB (2013) Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. The Journal of urology [doi]

Feng FY, Ghadessi M, Davicioni E, Crisan A, Erho N, Mitra AP, Triche TJ, Jenkins RB, Ross AE, Schaeffer EM (2013) Validation of a Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post-Radical Prostatectomy. International Journal of Radiation Oncology Biology Physics [doi]

Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, Bashashati A, Prentice LM, Khattra J, Burleigh A, Yap D, Bernard V,McPherson A, Shumansky K, Crisan A, Giuliany R, Heravi-Moussavi A, Rosner J, Lai D, Birol I, Varhol R, Tam A, Dhalla N, Zeng T, Ma K, Chan SK, Griffith M,Moradian A, Cheng SW, Morin GB, Watson P, Gelmon K, Chia S, Chin SF, Curtis C,Rueda OM, Pharoah PD, Damaraju S, Mackey J, Hoon K, Harkins T, Tadigotla V,Sigaroudinia M, Gascard P, Tlsty T, Costello JF, Meyer IM, Eaves CJ, WassermanWW, Jones S, Huntsman D, Hirst M, Caldas C, Marra MA, Aparicio S (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature [doi]

Roth A, Ding J, Morin R, Crisan A, Ha G, Giuliany R, Bashashati A, Hirst M, Turashvili G, Oloumi A, Marra MA, Aparicio S, Shah SP (2012) JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics [doi]

Vergara IA, Erho N, Triche TJ, Ghadessi M, Crisan A, Sierocinski T, Black PC, Buerki C, Davicioni E. (2012) Genomic dark matter in prostate cancer: exploring the clinical utility of ncRNA as biomarkers. Frontiers [doi]

Goya R, Sun MG, Morin RD, Leung G, Ha G, Wiegand KC, Senz J, Crisan A , Marra MA, Hirst M, Huntsman D, Murphy KP, Aparicio S, Shah SP (2010) SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics [doi]

Patents

Buerki C, Crisan A, Davicioni E, Erho N, Ghadessi M, Jenkins RB, Vergara IA (2013) Cancer diagnostics using biomarkers [doi]